High Level Abstraction (HLA) | Report |
---|
(1) (drug,eli_lilly,market) | 100.00 |
(2) (drug,eli_lilly,novo_nordisk,market) | 98.67 |
(3) (drug,loss,novo_nordisk,eli_lilly,market) | 97.10 |
(4) (drug,loss,novo_nordisk,market) | 95.55 |
(5) (drug,maritide,phipps) | 80.34 |
(6) (drug,market,novo_nordisk) | 73.81 |
(7) (loss,market,novo_nordisk) | 73.41 |
(8) (drug,loss,market,eli_lilly) | 69.44 |
(9) (drug,loss,maritide,vomiting) | 66.56 |
(10) (drug,loss,vomiting) | 65.76 |
(11) (loss,phipps,nausea) | 65.71 |
(12) (drug,maritide,vomiting) | 65.49 |
(13) (loss,phipps,vomiting) | 65.39 |
(14) (loss,treatments,vomiting) | 65.36 |
(15) (loss,vomiting) | 65.33 |
(16) (drug,loss,maritide,treatments) | 65.15 |
(17) (drug,loss,treatments) | 64.38 |
(18) (drug,maritide,treatments) | 64.08 |
(19) (loss,phipps,treatments) | 63.98 |
(20) (drug,loss,maritide,stop) | 63.79 |
(21) (loss,maritide,market) | 63.04 |
(22) (drug,loss,stop) | 63.02 |
(23) (drug,maritide,stop) | 62.72 |
(24) (loss,phipps,stop) | 62.62 |
(25) (loss,treatments,stop) | 62.54 |
(26) (drug,loss,maritide,phipps) | 62.40 |
(27) (loss,nausea) | 61.87 |
(28) (drug,loss,phipps) | 61.63 |
(29) (drug,loss,maritide,novo_nordisk) | 61.07 |
(30) (loss,maritide,novo_nordisk) | 60.41 |
(31) (drug,loss,maritide,nausea) | 60.14 |
(32) (drug,maritide,nausea) | 59.58 |
(33) (loss,treatments,nausea) | 59.18 |
(34) (drug,loss,maritide,market) | 57.85 |
(35) (drug,maritide,market) | 55.80 |
(36) (drug,eli_lilly,longer-lasting) | 55.29 |
(37) (drug,eli_lilly,novo_nordisk,longer-lasting) | 54.44 |
(38) (drug,loss,eli_lilly,longer-lasting) | 53.72 |
(39) (drug,loss,maritide,longer-lasting) | 53.00 |
(40) (drug,loss,market,longer-lasting) | 52.62 |
(41) (drug,loss,novo_nordisk,eli_lilly,longer-lasting) | 52.17 |
(42) (drug,loss,novo_nordisk,longer-lasting) | 51.43 |
(43) (drug,maritide,longer-lasting) | 51.19 |
(44) (drug,market,longer-lasting) | 51.03 |
(45) (loss,eli_lilly,longer-lasting) | 50.97 |
(46) (loss,eli_lilly,market,longer-lasting) | 50.73 |
(47) (loss,maritide,longer-lasting) | 50.44 |
(48) (loss,novo_nordisk,eli_lilly,longer-lasting) | 50.15 |
(49) (loss,novo_nordisk,eli_lilly,market,longer-lasting) | 49.96 |
(50) (loss,novo_nordisk,longer-lasting) | 49.64 |
(51) (market,novo_nordisk,eli_lilly,longer-lasting) | 49.51 |
(52) (market,novo_nordisk,longer-lasting) | 49.45 |
(53) (drug,eli_lilly,novo_nordisk,leaders) | 49.35 |
(54) (drug,loss,eli_lilly,leaders) | 48.63 |
(55) (drug,company,targets) | 48.41 |
(56) (drug,loss,maritide,leaders) | 47.75 |
(57) (drug,loss,market,leaders) | 47.32 |
(58) (drug,loss,novo_nordisk,eli_lilly,leaders) | 46.92 |
(59) (drug,loss,novo_nordisk,leaders) | 46.02 |
(60) (drug,maritide,leaders) | 45.72 |
(61) (drug,market,leaders) | 45.56 |
(62) (loss,eli_lilly,leaders) | 45.51 |
(63) (loss,eli_lilly,market,leaders) | 45.22 |
(64) (loss,maritide,leaders) | 44.84 |
(65) (loss,novo_nordisk,eli_lilly,leaders) | 44.52 |
(66) (loss,novo_nordisk,eli_lilly,market,leaders) | 44.28 |
(67) (loss,novo_nordisk,leaders) | 43.88 |
(68) (market,novo_nordisk,eli_lilly,leaders) | 43.73 |
(69) (market,novo_nordisk,leaders) | 43.67 |
(70) (drug,loss,maritide,eli_lilly) | 43.38 |
(71) (loss,eli_lilly,maritide) | 41.81 |
(72) (loss,eli_lilly,market,maritide) | 41.17 |
(73) (loss,novo_nordisk,eli_lilly,maritide) | 40.42 |
(74) (loss,novo_nordisk,eli_lilly,market,maritide) | 39.89 |
(75) (drug,loss,novo_nordisk,eli_lilly,maritide) | 38.77 |
(76) (drug,eli_lilly,manufacture) | 36.53 |
(77) (drug,eli_lilly,novo_nordisk,manufacture) | 35.86 |
(78) (drug,loss,eli_lilly,manufacture) | 35.41 |
(79) (drug,late-stage,glp-1) | 34.88 |
(80) (drug,loss,novo_nordisk,eli_lilly,manufacture) | 34.56 |
(81) (drug,loss,novo_nordisk,manufacture) | 33.97 |
(82) (loss,eli_lilly,manufacture) | 33.49 |
(83) (loss,novo_nordisk,eli_lilly,manufacture) | 33.28 |
(84) (loss,novo_nordisk,manufacture) | 33.12 |
(85) (drug,loss,company) | 33.04 |
(86) (drug,retatrutide) | 32.56 |
(87) (drug,glp-1,targets,company) | 32.56 |
(88) (drug,loss,market,company) | 32.21 |
(89) (company,loss,twice-a-day) | 31.25 |
(90) (company,twice-a-day) | 31.23 |
(91) (drug,company,twice-a-day) | 30.88 |
(92) (drug,loss,market,twice-a-day) | 30.59 |
(93) (drug,loss,twice-a-day) | 29.90 |
(94) (drug,market,twice-a-day) | 29.71 |
(95) (market,company,twice-a-day) | 29.52 |
(96) (market,twice-a-day) | 29.44 |
(97) (company,loss,once-daily) | 29.36 |
(98) (drug,company,once-daily) | 29.10 |
(99) (drug,loss,market,once-daily) | 28.67 |
(100) (drug,market,once-daily) | 28.30 |